Fiji vs Myanmar: Antiretroviral therapy coverage for PMTCT
Fiji
57.0%
in 2024
Myanmar
54.0%
in 2024
Fiji rank
63rd
Myanmar rank
65th
Antiretroviral therapy coverage for PMTCT over time
- Fiji
- Myanmar
How they compare
Fiji currently reports 57.0% against 54.0% in Myanmar, a difference of 3.0%.
That makes Fiji's figure about 1.1 times Myanmar's.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Myanmar ahead.
Fiji ranks 63rd and Myanmar ranks 65th of 84 countries.
Across the 3 decades both report, Fiji averaged higher in 2 and Myanmar in 1.
Head to head by decade
| Decade | Fiji | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.4% | 13.8% | 12.6% | Fiji |
| 2010s | 71.6% | 69.7% | 1.9% | Fiji |
| 2020s | 31.0% | 51.8% | 20.8% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Fiji or Myanmar?
- Fiji, at 57.0% against 54.0% in Myanmar as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Fiji and Myanmar?
- 3.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Myanmar?
- 25 years are reported by both, from 2000 to 2024.
- How do Fiji and Myanmar rank globally for antiretroviral therapy coverage for pmtct?
- Fiji ranks 63rd and Myanmar ranks 65th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).